acyl-coenzyme A:cholesterol acyltransferase; cholesterol 7␣-hydroxylase; 3-hydroxy-3-methyglutaryl-CoA reductase; lowdensity lipoprotein receptor; liver; neutral cholesterol ester hydrolase CHOLESTEROL IS SYNTHESIZED in essentially all cells in the human body. It serves as a structural component of cell membranes and as a precursor for steroid hormones and bile acids. Cholesterol also plays a role as a regulatory molecule for several enzymes in the pathways of cholesterol metabolism in the liver (21) . Bile acid synthesis from cholesterol is a major pathway for elimination of cholesterol from the body, occurring either via the classic (also called "neutral") or alternative (also called "acidic") bile acid biosynthetic pathways (54) . Cholesterol 7␣-hydroxylase (CYP7A1) and sterol 27-hydroxylase (CYP27) are initial and rate-determining enzymes in the classic and alternative pathways, respectively. CYP7A1 and CYP27 are subject to regulation by bile acids and certain hormones (54) . The contribution of the alternative pathway to bile acid synthesis is not precisely known and may be species dependent. In the rat, the estimated contribution may be as high as 50% (36, 45, 55) , whereas in humans, the contribution may be Ͻ10% (10, 15, 51) .
Excess cholesterol accumulation in the body is associated with two major diseases of Western civilization, i.e., atherosclerosis and cholesterol gallstones. Cholesterol accumulation reflects excess cholesterol input into the body, reduced cholesterol elimination, or both. The effects of excessive cholesterol input via de novo cholesterol synthesis or via an increase in dietary cholesterol on serum cholesterol levels are well known (21) . The importance of cholesterol degradative pathways, i.e., bile acid synthesis, on overall cholesterol homeostasis and serum cholesterol levels is less well understood. Different species differ widely in their response to dietary cholesterol load. The rat responds to cholesterol feeding with induction of CYP7A1 and bile acid synthesis via the classic pathway (33) and is relatively resistant to development of hypercholesterolemia. In contrast, increased dietary cholesterol fails to induce CYP7A1 in rabbits (57) , Green monkeys (37), and hamsters (19, 32) . In these species, excess cholesterol leads to the development of hypercholesterolemia and atherosclerosis. The ability of most humans to respond to a cholesterol load is probably more akin to hamsters, but some humans can process excessive dietary cholesterol by increasing their bile acid synthesis rate (8, 25) .
A seminal study by Spady et al. (42) demonstrated that overexpression of CYP7A1 in hamsters fed a diet high in cholesterol resulted in enhanced bile acid synthesis and prevented an increase in low-density lipoprotein (LDL) cholesterol levels. The results of this study firmly established the importance of bile acid biosynthetic pathways in the pathogenesis of hypercholesterolemia and atherosclerosis. Similar data were obtained in mice lacking the LDL receptor gene in which increased expression of hepatic CYP7A1 also lead to a 50% reduction in plasma LDL cholesterol concentrations (43) . No similar data are available in humans.
Cholesterol homeostasis in the liver is governed by several key regulatory enzymes and receptors, including 1) HMG-CoA reductase (HMGR), the rate-determining step in the cholesterol biosynthetic pathway; 2) CYP7A1 and CYP27, the initial enzymes in the classic and alternative pathways of bile acid biosynthesis, respectively; 3) acyl-coenzyme A:cholesterol acyltransferase (ACAT) and neutral cholesterol ester hydrolase (CEH), the two enzymes that regulate the sizes of free and esterified cholesterol compartments in the liver; and 4) cholesterol uptake via LDL and other lipoprotein receptors (21) . The ability of each of these to respond to changes in a metabolically active sterol pool within the liver is the basis for how cholesterol homeostasis is maintained.
In the present study, we determined the effects of overexpression of CYP7A1 on several parameters of bile acid and hepatic cholesterol metabolism in primary human hepatocytes (PHH) and in HepG2 cells, a wellcharacterized human hepatoblastoma cell line (34) . The data show that overexpression of CYP7A1 in cultured cells derived from humans resulted in a marked increase of bile acid synthesis via the "classic" pathway. Alterations of hepatic cholesterol metabolism that have not been previously reported and that differ from the changes observed in other species, were also noted.
MATERIALS AND METHODS

Materials.
All cell culture materials were obtained from GIBCO BRL (Grand Island, NY) unless otherwise specified. William's E medium was purchased from GIBCO BRL. The CsCl, agarose, and RNA ladder used to size CYP7A1 mRNA were also purchased from GIBCO BRL. Taurocholate and cholesterol oxidase were purchased from Calbiochem (San Diego, CA). All other chemicals used were obtained from Sigma Chemical (St. Louis, MO) or Bio-Rad Laboratories (Hercules, CA) unless otherwise specified. ␤-Cyclodextrin was purchased from Cylcodextrin Technologies Development (Gainesville, FL). All solvents were obtained from Fisher Scientific (Fair Lawn, NJ) unless otherwise indicated. All radionucleotides, aquasol solution, and enhanced chemiluminescence reagents were purchased from DuPont NEN (Boston, MA). Poly Attract mRNA isolation system II was obtained from Promega (Madison, WI). The nick translation kit was obtained from Bethesda Research Laboratories (Grand Island, NY), and Tri-Reagent was purchased from Molecular Research Center (Cincinnati, OH). Nylon membranes were purchased from Micron Separation (Westborough, MA). Silica gel thin-layer chromatography plates (LK6 D) were from Whatman (Clifton, NJ).
Generation of recombinant adenovirus encoding rat CYP7A1. The AdCMV-CYP7A1 and AdCMV-␤-gal adenovirus clones were constructed in an AD5dl309 adenovirus strain (24) essentially as previously described (53) . Briefly, for AdCMV-CYP7A1, a 2.6-kb rat cDNA encoding CYP7A1 was obtained from Dr. John Chiang (7) and was cloned into the EcoR I site of pADCMV. Plasmid pAdCMV (7.7 kb) was constructed from a pGEM4Z (Promega) backbone and contained AD5dl309 sequence on either side of the CMV promoter/multiple cloning site region of pcDNA3 (Invitrogen, Carlsbad, CA). The resulting pAdCMV/CYP7A1 recombinant plasmid was cotransfected with the right arm (XbaI digest) of Ad5dl309 into 293 cells (16) . Adenovirus DNA isolated from resulting plaques were screened by Southern blot for the presence of the CYP7A1 insert.
Propagation of AdCMV-CYP7A1. Large-scale production of recombinant virus was performed by infecting confluent monolayers of human embryonic kidney 293 cells (American Type Culture Collection, Rockville, MD) grown in 15-cm tissue culture dishes with stock adenovirus at a multiplicity of 1 plaque-forming units/cell. After 2 h of infection, the virus was removed and replaced with DMEM with 2% fetal bovine serum (FBS). The infected monolayers were harvested by scraping when Ͼ90% of the cells showed cytopathic changes and were then centrifuged at 2,700 g, 4°C, for 10 min. The cellular pellet was suspended in DMEM/2% FBS and subjected to five cycles of freeze-thaw lysis to release the virus. Cell debris was removed by centrifugation at 7,700 g, 4°C, for 5 min. To purify, the crude supernatant fluid was carefully layered over a twostep gradient containing 3 ml of CsCl (density ϭ 1.4 g/ml) in Tris dialysis (TD) buffer (0.14 M NaCl, 5 mM KCl, 19 mM Tris pH 7.4, 0.7 mM Na 2 HPO4) layered over 3 ml of CsCl (d ϭ 1.25 g/ml) in TD buffer, and centrifuged at 155,000 g, 20°C, 1 h. The viral band was removed, layered over 8 ml of CsCl (d ϭ 1.33 g/ml) in TD buffer and centrifuged at 155,000 g, 20°C, 18 h. The pure viral opalescent band was removed and dialyzed against 10 mM Tris HCE pH 7.4, 1 mM MgCl2, 10% glycerol, overnight at 4°C. The virus was aliquoted and stored at Ϫ70°C. The virus titer (pfu) was determined by plaque assay, and viral particles were determined by optical density using spectrophotometry ( ϭ 260).
Infection of HepG2 cells with AdCMV-CYP7A1. HepG2 cells were grown in 162-cm 2 (25-ml) tissue culture flasks until they were 80-90% confluent as described previously (34) in MEM containing nonessential amino acids, 0.03 M NaCO3, 10% FBS, 1 mM L-glutamine, 1 mM sodium pyruvate, and 1% Pen/Strep and were incubated at 37°C in 5% CO2. Before infection, 15 ml of culture medium was removed. Control flasks (i.e., no addition of adenovirus) were treated in a similar manner. HepG2 cells were then infected with Ad-CMV-CYP7A1 with a multiplicity of infection of 1 using virus in a volume of 0.4-4 ml. The virus was allowed to dwell for 3 h. After an additional 15 ml of fresh medium was added back to the flasks, they were allowed to incubate at 37°C, 5% CO2 for 72 h. Toxicity to cells was assessed as previously described (34) . Limited additional studies were done in the absence of FBS (i.e., serum-free media). Of note is that each value designated as N is the mean of duplicate-to-triplicate cultures for each condition measured during the same setting.
Cells were divided in half and harvested in two distinct buffers as previously described (34, 35) . One-half of the cells was used to isolate microsomes for measurement of HMGR and CYP7A1 specific activities. The remainder was used to isolate microsomes and cytosol for measurement of ACAT and CEH specific activities, respectively (35) . In brief, the cells were scraped and suspended in the appropriate buffer. Cell disruption was performed by using a Sonifier cell disruptor 350 (Branson Sonic Power) for 1 min at an output of 3. Microsomes were isolated from cellular extracts by centrifugation at 660 g. The supernatant fluid was centrifuged at 105,000 g. The resulting microsomal pellets were suspended in the appropriate buffer by using a hand-driven homogenizer and were stored at Ϫ70°C until assayed for activity. The microsomal protein concentration was determined by the Bradford procedure (2), using BSA as a standard.
Isolation and culture of primary human hepatocytes. Primary human hepatocytes were isolated according to the method of Strom et al. (46, 47) . Before plating, cells were judged to be Ͼ90% viable by use of trypan blue exclusion. Cells were then plated onto 150-mm plastic Petri dishes previously coated with rat tail collagen and were incubated in 20 ml of William's E medium supplemented with insulin (0.25 units/ml) and penicillin (100 units/ml) in a 5% CO2 atmosphere at 37°C. Cells were routinely harvested at 72 h of culture as previously described by our laboratory (45) . Unless otherwise indicated, culture medium contained 0.1 M dexamethasone and 1.0 M L-thyroxine. Toxicity was assessed as previously described in the experiments using primary rat hepatocytes (45) .
Primary human hepatocytes were plated in P150-cm 2 plates to confluency (ϳ2.5 ϫ 10 7 cells). Twenty-four hours after plating, culture medium was removed, and 2.5 ml of fresh medium were added. Cells were then infected with a replication defective adenovirus containing CMV-CYP7A1 or control virus (replicative defective adenovirus without CMV-CYP7A1) with an MOI of 10. The virus was allowed to dwell for at least 2 h in minimal culture medium by shaking the plates gently every 15 min, after which the medium containing unbound virus was removed and 20 ml of fresh medium were added back to the plates and allowed to incubate at 37°C, 5% CO 2 for an additional 48 h. Cells were then harvested for the isolation of microsomes and RNA. Viral toxicity was determined by trypan blue exclusion and lactic dehydrogenase release as previously described in primary rat hepatocytes in culture (27, 45) . Proper approval for these studies was obtained through the university institutional review board. More specifically, PHH cultures were obtained from the following livers: 58-yr-old Hispanic man involved in a motor vehicle accident (cells used for RNA and bile acid synthesis), 45-yr-old Caucasian man with an intracranial hemorrhage (cells used for bile acid synthesis and CYP7A1 specific activity), and 15-yr-old African-American woman with drug intoxication (cells used for RNA).
Analysis of conjugated bile acids. Conjugated bile acids were extracted according to the method of Folch et al. (11) . Conjugated bile acids in the culture medium aspirated from HepG2 cells were analyzed by gas liquid chromatography (GLC) by the methods of Setchell and Worthington (40) . The conversion of [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]cholesterol into MeOH: H2O-soluble materials was used as an indication of bile acid synthesis.
Determinations of enzyme specific activities. The specific activity of CYP7A1 was determined in microsomes by using a HPLC assay described previously (22) . HMGR specific activity was assayed as described by Whitehead et al. (56) . Neutral cytosolic CEH specific activity was determined according to the methods of Ghosh et al. (13) . ACAT specific activity was determined by the method of Burrier et al. (4) Microsomal free and total cholesterol were determined by HPLC analysis. Free cholesterol was converted to cholest-4-ene-3-one by using cholesterol oxidase as previously described (22) . Total cholesterol was measured as free cholesterol after saponification.
Experiments involving the exogenous addition of 7␣-hydroxycholesterol. In an attempt to further define the effects of 7␣-hydroxycholesterol on the specific activity of HMGR, 7␣-hydroxycholesterol was added to cell culture medium in molecusol (3 mg 7␣-hydroxycholesterol to 1 ml ␤-cyclodextrin) to obtain final concentrations of 1, 25, and 50 M. Microsomes were harvested 24 h after the addition of the 7␣-hydroxycholesterol, and endogenous microsomal 7␣-hydroxycholesterol levels and HMG-R specific activities were then determined. As reference, 7␣-hydroxycholesterol serum levels have been reported to be in the range of 0.01-2.2 M in healthy humans (3) . In other studies, the addition of 6-12 M concentrations of 7␣-hydroxycholesterol have not been shown to downregulate HMG-R activity in HepG2 cells (23) . 7␣-Hydroxycholesterol-induced cell toxicity was assessed as previously described (34) .
Quantitation of mRNA levels. Methods for the isolation of RNA and the determination of mRNA levels by Northern blotting have been previously described (33) . Rat cyclophilin cDNA was used as the internal loading standard. The cDNA probes used were as follows: CYP7A1 (28); HMGR (26); LDL receptor (LDLR; pLDLR3 was obtained from American Type Culture Collection); ACAT (6); CEH (13); CYP27 (48); and cyclophilin (9). Fig. 1 is a representative comparison of CYP7A1 mRNA levels in HepG2 cells infected with AdCMV-CYP7A1 vs. control cells. Infection with this recombinant adenovirus (AdCMV-CYP7A1) led to a marked increase in CYP7A1 mRNA levels (11,107 Ϯ 372%; P Ͻ 0.01) compared with control cells. To more easily detect basal CYP7A1 mRNA levels in control cells, it was necessary to isolate and probe poly A mRNA (34) . However, after infection with AdCMV-CYP7A1, CYP7A1 mRNA levels were easily detectable by use of total RNA. Analysis of RNA isolated from AdCMV-CYP7A1 infected cells showed the 3.6-kb CYP7A1 band was not detectable, whereas when poly A was probed from control cells, the usual three bands at 3.6, 2.5, and 1.2 kb were detected (34) . To ensure that the adenovirus itself was having no effect on CYP7A1 mRNA levels, HepG2 cells were also infected with a recombinant adenovirus encoding ␤-galactosidase (AdCMV␤Gal). No increase in CYP7A1 mRNA was observed in those cells (see Fig. 8 ). These data demonstrate that highly effective overexpression of CYP7A1 could be accomplished in HepG2 cells. Fig. 2 shows a marked increase in CYP7A1 specific activity in HepG2 cells after infection with AdCMV-CYP7A1 compared with control, noninfected cells. Activity in HepG2 cells increased from undetectable levels in uninfected cells to 44.4 Ϯ 2 nmol⅐ h Ϫ1 ⅐ mg Ϫ1 for virus-infected cells. Preformed 7␣-hydroxycholesterol was also undetectable in uninfected cells, whereas sig-nificant levels were detected in the infected cells (Table  1) .
RESULTS
Studies in HepG2 cells. Shown in
To ensure that the recombinant adenovirus itself was not having a stimulatory effect on CYP7A1 specific activity, specific activity was determined in cells infected with AdCMV-␤Gal, a representative control recombinant adenovirus. Shown in Fig. 3 are representative HPLC tracings demonstrating levels of 7␣-hydroxycholesterol in cells infected with AdCMV-CYP7A1 (Fig. 3A) vs. AdCMV-␤Gal (Fig. 3B) . A large amount of 7␣-hydroxycholesterol was observed after infection with AdCMV-CYP7A1. No 7␣-hydroxycholesterol was detected after AdCMV-␤Gal (i.e., no specific activity). Control uninfected HepG2 cells also had no detectable CYP7A1 activity (see Fig. 2 ). These representative tracings demonstrate that control recombinant adenovirus had no stimulatory effect on endogenous CYP7A1 expression. Not shown are tracings demonstrating no stimulatory effect of control virus (AdCMV-␤Gal) on CYP7A1 activity compared with uninfected cells.
An approximately twofold increase in total bile acids synthesized by HepG2 cells was observed in the culture medium after CYP7A1 overexpression. [ (Fig. 4A) . The percent increase in bile acid synthesis was in agreement with the increase in primary bile acids (cholic and chenodeoxycholic acid) measured in the medium as determined by GLC (Fig. 4B) . Using GLC analysis, we found an increase of 98 Ϯ 9.5% (P Ͻ 0.05) over paired controls in bile acid concentration (i.e., synthesis) in the medium in the cells infected with AdCMV-CYP7A1 (Fig. 4B) . The composition of the primary bile acids in HepG2 cell culture medium was largely chenodeoxycholic acid in control cells, with approximately equal proportions of cholic and chenodeoxycholic acid after CYP7A1 overexpression (Fig. 5) . In limited studies, HepG2 cells were grown in serum-free medium compared with the serum-containing conditions employed above. As in HepG2 cells grown in serum-containing medium, cells grown in serum-free medium increased bile acid synthesis after CYP7A1 overexpression, but to a lesser degree (130%; P Ͻ 0.05). This lower rate of bile acid synthesis after CYP7A1 overexpression in a growing cell line in the absence of cholesterol-containing serum is most likely a function of a decreased cholesterol pool availability for bile acid synthesis (i.e., absence of medium cholesterol uptake).
The impact of overexpression of CYP7A1 on cellular cholesterol homeostasis is reflected in changes in HMGR, ACAT, and CEH specific activities. A decrease in HMGR specific activity (234 Ϯ 7%; P Ͻ 0.01) was observed in AdCMV-CYP7A1-infected cells compared with uninfected control cells (Fig. 6) . Overexpression of CYP7A1 in HepG2 cells also perturbed hepatocellular cholesterol esterification and storage, as can be seen by the changes in cytosolic CEH and microsomal ACAT specific activi- Fig. 1 . Representative Northern blot of cholesterol 7␣-hydroxylase (CYP7A1) mRNA levels in HepG2 cells after infection with AdCMV-CYP7A1. HepG2 cells were grown until 80-90% confluent under optimal culture conditions. Cells infected with AdCMV-CYP7A1 as described under MATERIALS AND METHODS are compared with control (CTRL) cells (no viral infection). Cells were harvested 72 h after infection, and mRNA levels for CYP7A1 and cyclophilin (loading standard) were determined. Fig. 2 . Effect of infection with AdCMV-CYP7A1 on CYP7A1 specific activity in HepG2 cells. HepG2 cells were grown until 80-90% confluent under optimal culture conditions and then were infected with AdCMV-CYP7A1 as described under MATERIALS AND METHODS. Cells were harvested 72 h after infection, and specific activity for CYP7A1 was determined. Data are expressed as means Ϯ SE. CYP7A1 specific activity was not detectable in control cells. Preformed 7␣-hydroxycholesterol (endogenous) was also not found in control cells, whereas endogenous microsomal 7␣-hydroxycholesterol was easily detected in infected cells before incubation (Table 1) .
ties. Specific activity of neutral CEH increased 38 Ϯ 5% (P Ͻ 0.01) after infection with AdCYP7A1 compared with uninfected control cells (Fig. 6) . A 56 Ϯ 7% (P Ͻ 0.01) decrease in ACAT specific activity occurred in HepG2 cells infected with AdCMV-CYP7A1.
A significant increase in LDLR mRNA levels (41 Ϯ 16%; P Ͻ 0.01) was seen in HepG2 cells after infection with AdCMV-CYP7A1 compared with uninfected controls (Fig. 7) . LDLR mRNA levels were not affected in cells infected with AdCMV-␤Gal adenovirus lacking CYP7A1. HMGR and ACAT mRNA levels were decreased 28 (n ϭ 2; range 223-34%) and 25% (n ϭ 2; range 217-34%), respectively. CEH mRNA levels were increased 19% (n ϭ 2; range 112-25%). A representative Northern blot comparing control HepG2 cell mRNA levels with recombinant control virus (AdCMV-␤Gal) and AdCMV-CYP7A1 shown in Fig. 8 supports these cumulative results. With the exception of LDLR, for which receptor activity was not measured, changes in HMGR, ACAT, and CEH mRNA levels correlated with changes observed in their respective specific activities. In limited studies, HepG2 cells were also grown in serum-free medium as opposed to the serum-containing conditions employed above. As in HepG2 cells grown in serum-containing medium, LDLR mRNA increased (154 Ϯ 27%; P Ͻ 0.05) in cells grown in serum-free medium after CYP7A1 overexpression.
Overexpression of CYP7A1 also led to changes in microsomal free and total cholesterol (Fig. 9) . A 27 Ϯ 1% (P Ͻ 0.01) decrease in microsomal free cholesterol was seen after infection with AdCMV-CYP7A1 in HepG2 cells (control cell microsomal free cholesterol levels, 200 nmol/mg microsomal protein). A corresponding decrease (2 45%; n ϭ 2) in microsomal total cholesterol was also noted with increased expression of CYP7A1.
After overexpression of CYP7A1, increased endogenous microsomal levels of 7␣-hydroxycholesterol were observed. As demonstrated ( Fig. 6; Table 1 ), the increase in these levels was associated with lower HMGR specific activities. Previously, it has been suggested that 7␣-hydroxycholesterol may be one of several oxysterols capable of downregulating HMGR. To further substantiate this hypothesis, additional studies were performed in which 7␣-hydroxycholesterol was added directly to culture medium (Table 1) . Concentrations attempting to approximate and exceed previously documented human serum values were chosen. A range of 0.01-2.2 M has previously been demonstrated in the serum of healthy humans (3) . A concentration of 6-12 . By using laser densitometry, mRNA levels were calculated as a ratio of mRNA of interest to that of cyclophilin, employed as an internal loading standard.
M of 7␣-hydroxycholesterol had not previously been shown to downregulate HMGR activity in HepG2 cells (23) . In our studies, the addition of 7␣-hydroxycholesterol to medium to obtain a 1 M concentration had no effect on HMGR activity. However, 25 M and 50 M concentrations of 7␣-hydroxycholesterol in the medium led to a concentration-dependent decrease in HMGR activity (Table 1) . Microsomal 7␣-hydroxycholesterol concentrations after CYP7A1 overexpression were between that of the 25 M and 50 M 7␣-hydroxycholesterol medium concentrations, with the decrease in HMGR most closely approximating the effects of 25 M (Table 1) .
Studies in primary human hepatocytes. Figure 10 shows a representative Northern blot of CYP7A1 mRNA levels in PHH control cells (addition of control adenovirus) compared with mRNA levels in cells infected with AdCMV-CYP7A1. There is evidence for abundance of mRNA levels in infected (PHH) compared with control cells in which the mRNA levels are practically undetectable. Cyclophilin controls showed no changes in either control or infected cells.
In Fig. 11 , we show quantitative data on CYP7A1 mRNA levels and the specific activities in PHH. In contrast to control HepG2 cells in which CYP7A1 specific activity was undetectable (Fig. 2) , PHH controls had detectable CYP7A1 activity (0.13 nmol ⅐ h Ϫ1 ⅐ mg Ϫ1 protein). After overexpression of CYP7A1, steady-state mRNA levels increased ϳ18-fold, whereas specific activities increased Ͼ10-fold. These data are consistent with significant augmentation of CYP7A1 after infection with AdCMV-CYP7A1 virus. HepG2 cells were grown until 80-90% confluent under optimal culture conditions. Cells were infected with AdCMV-CYP7A1 or AdCMV-␤Gal as described under MATERIALS AND METHODS. Cells were harvested 48 h after infection, and mRNA levels for LDL-R, HMGR, CYP7A1, ACAT-1, CEH, and cyclophilin (loading standard) were determined. Note: Despite the attempt to generate a blot with the same RNA loading in all columns, mRNA levels in the ␤Gal column were less as determined by use of cyclophilin as an internal loading standard. Infected: HepG2 cells infected with AdCMV-CYP7A1. Additions: 7␣-hydroxycholesterol was added to HepG2 cell culture medium to achieve 1, 25, and 50 M medium concentrations. Microsomes were harvested 24 h after addition of the 7␣-hydroxycholesterol, and endogenous 7␣-hydroxycholesterol microsomal concentrations were determined (means Ϯ SE). HMGR, HMG-CoA reductase specific activity expressed as a percent of paired controls. Bile acid synthesis in primary human hepatocytes (Fig. 12) after infection with AdCMV-CYP7A1 increased 73% (n ϭ 2; range 162-82%) at 22 h and 393% (n ϭ 2; range 1341-447%) at 48 h. These data show that the marked increase in CYP7A1 mRNA levels and specific activities after CYP7A1 overexpression is translated into a significant increase of bile acid synthesis and fully supports the stimulation of the classic pathway of bile acid synthesis.
Simultaneously, a significant increase occurred in LDLR mRNA levels (Fig. 13) in PHH after infection with AdCMV-CYP7A1 compared with paired controls. Cyclophilin levels did not change, suggesting that unequal blot RNA loading could not account for increases in LDLR mRNA levels. Similar to HepG2 cells, HMGCoA reductase activity decreased 67% (mean of 3 cultures; n ϭ 1) in PHH infected with AdCMV-CYP7A1.
DISCUSSION
In the present paper, we provide evidence that overexpression of CYP7A1 in HepG2 and in PHH results in an increase in bile acid synthesis via the classic pathway coupled with suppression of cholesterol synthesis. These findings are particularly noteworthy because they differ in several respects from responses observed in other species. Most of the information on the mechanism by which cholesterol homeostasis is maintained has been derived from experimental animals, which showed a great deal of species variation (19, 33, 37, 57) . The rat is capable of inducing CYP7A1 and bile acid synthesis in response to a diet high in cholesterol (33) . The resulting increase in cholesterol degradation appears to protect this species from hypercholesterolemia and atherosclerosis. In humans, the response to dietary cholesterol appears to be heterogeneous. A trend toward increasing LDL cholesterol by increasing dietary cholesterol is well established, but in a significant number of humans, circulating LDL cholesterol does not change in response to changes in dietary cholesterol (8, 25) . In an interesting paper by Kern (25) , a single patient consuming 25 eggs per day for over 20 years had a marked increase in the rate of bile acid synthesis coupled with near normal serum cholesterol levels. This combination of findings suggests that, in this particular individual, CYP7A1 was inducible by a diet high in cholesterol in a manner similar to that of rat. Couture et al. (8) studied the effect of A to C substitution at position Ϫ204 of the promoter of CYP7A1 gene and its association with variations in Fig. 11 . Effect on CYP7A1 mRNA levels and specific activity in primary human hepatocytes after infection with AdCMV-CYP7A1. Hepatocytes were incubated for 24 h in culture medium containing optimal concentrations of T4 (1.0 M) and dexamethasone (0.1 M). At 24 h cells were infected with control virus or AdCMV-CYP7A1 as described under MATERIALS AND METHODS. Cells were harvested 48 h after infection, and mRNA levels and specific activity for CYP7A1 were determined. Data are expressed as percent of paired controls. plasma LDL cholesterol concentrations. At least in humans, the C variant was associated with higher plasma LDL cholesterol concentrations and an increase in the ratio of total cholesterol to high-density lipoprotein. Although overexpression of CYP7A1 in hamsters prevents hypercholesterolemia in animals fed a Western diet (42), it is not certain whether such observations can be extrapolated from other species to humans.
We have previously characterized HepG2 cells and found them a good model to study the regulation of human CYP7A1 and other enzymes of the bile acid biosynthetic pathways. HepG2 cells were shown to synthesize primary bile acids and express enzymes and receptors involved in the maintenance of cholesterol homeostasis (34) . PHH have been used to study numerous aspects of cholesterol and bile acid transport and metabolism and have been shown to be a valid model to study the physiological and metabolic events in humans. To further verify the results in HepG2 cells, we also repeated some key experiments in PHH for comparison purposes. The data in the two systems are consistent and differ somewhat from those obtained in other species.
In AdCMV-CYP7A1-infected HepG2 cells, CYP7A1 mRNA levels and specific activities increased severalfold. Bile acid synthesis increased approximately twofold with the associated increase in CYP7A1 expression. No such increase occurred in control cells or cells infected with a control adenovirus. After infection with the AdCMV-CYP7A1, the concentration of cholic acid in the medium increased from Ͻ10% to nearly 50% of total bile acid synthesis. This increase in the proportion of cholic acid suggests that in humans the classic pathway is mainly responsible for synthesis of cholic acid. Previous in vitro and in vivo studies in the rat suggest that up to 50% of total bile acid synthesis may occur via the alternative pathway and that the predominant bile acid is chenodeoxycholic acid (36, 45, 55) . How representative this finding is to other species is uncertain. In contrast to findings in the rat, Duane and Javitt (10) have recently reported that in healthy humans Ͻ10% of total bile acid synthesis appeared to be synthesized via the alternative pathway; their findings are consistent with previous reports (15, 51) . In our recent experiments, overexpression of CYP27 in Chinese hamster ovary cells and HepG2 cells led to a modest increase in 27-hydroxycholesterol and bile acid synthesis, respectively (18) . These data suggested that the alternative pathway may be induced in human-derived liver cell lines. In the CYP7A1 knockout mouse, in which the classic pathway of bile acid synthesis is absent, the alternative pathway can become activated and produce sufficient bile acid synthesis to permit survival without exogenous bile acid supplements (39) .
A marked increase of CYP7A1 specific activity and bile acid synthesis in both types of cells was coupled with compensatory changes in hepatic cholesterol metabolism, including increased LDLR mRNA levels. Surprisingly, the overexpression of CYP7A1 in HepG2 cells was associated with a decrease in HMGR activity. This finding is different from in vivo observations by Spady et al. (42) , and in vitro observations by Spitsen et al. (44) and Sudjana-Sugiaman et al. (50) . In general, HMGR and CYP7A1 change in tandem, resulting in coordinate regulation of cholesterol and bile acid synthesis. The previous in vivo and in vitro studies (42, 44, 50) were carried out by infection of the CYP7A1 gene into hamsters or nonhuman, nonhepatic cell lines. HepG2 cells have been shown to reflect in vivo events in humans, and because a decrease in HMGR activity after overexpression of CYP7A1 was a reproducible finding, one can conclude that the behavior of HMGR in HepG2 cells (i.e., extrapolated to humans) may be different from that in the rat and other species. Our limited findings in PHH in this study support of this finding.
Although the decrease in HMGR in the face of markedly upregulated CYP7A1 was not expected, a plausible explanation is available. The ability of oxysterols to repress HMGR is well documented in several studies (3, 30, 41 ). In our model, overexpression of CYP7A1 results in formation of a large amount of 7␣-hydroxycholesterol, which in turn may repress HMGR. This was confirmed by adding 7␣-hydroxycholesterol to the culture medium (Table 1) . These experiments, therefore, strongly suggest that 7␣-hydroxycholesterol or a derivative may be responsible for the observed feedback repression of HMGR under these experimental circumstances. Increasing CYP7A1 activity directly in hepatocytes might not only stimulate increased cholesterol catabolism, but also simultaneously repress HMGR. This approach differs from the secondary upregulation of CYP7A1 and HMGR associated with feeding the intestinal bile acid-binding resin, cholestyramine. With cholestyramine feeding, the increased intestinal loss of bile acids stimulates bile acid synthesis via a reduction in negative bile acid biofeedback with a subsequent increase in HMGR activity. Although the serum concentration of 7␣-hydroxycholesterol has been shown to increase with cholestyramine feeding (1), the microsomal levels achieved and the relationship to this study are not clearly defined. One explanation for the differing findings in this study compared with those of previous studies is the level of microsomal 7␣-hydroxycholesterol.
The effect of 7␣-hydroxycholesterol in the regulation of the LDLR is even less clear, with previous effects clearly dependent on oxysterol cellular concentration (29, 31) . These results suggest a differential effect of 7␣-hydroxycholesterol on HMGR and LDLR regulation. The fact that HMGR and LDLR usually also change in tandem suggests that intracellular concentrations of 7␣-hydroxycholesterol can lead to a differential regulation in HMGR and LDLR. As transcriptional control of HMGR and LDLR are believed to be controlled by the same factor (22) , one could postulate that 7␣-hydroxycholesterol could be mediating its regulation of HMGR through acceleration of mRNA degradation.
Our findings suggest that sufficiently increased CYP7A1 activity with a subsequent increase in 7␣-hydroxycholesterol microsomal concentrations will ex-hibit a cholesterol homeostatic response favorable to lowering serum cholesterol. The physiological significance of the large increase in CYP7A1 activity achieved in vitro compared with what can be achieved in vivo is uncertain. However, if this observation can be confirmed in in vivo experiments, it would suggest that overexpression of CYP7A1 may be a highly effective strategy for lowering serum cholesterol in humans.
The ability of ACAT to esterify cholesterol is important in maintaining intracellular concentrations of free cholesterol as well as providing cholesterol storage in the form of cholesterol esters. In the liver, ACATderived cholesterol esters are secreted as a component of very-low-density lipoproteins. ACAT activity is upregulated by LDL and free cholesterol (49, 52) . In general, as free cholesterol substrate increases, so does ACAT activity, to maintain free cholesterol in the narrow range. In the presence of decreased cholesterol availability, the activity of ACAT has been shown to decrease (49, 52) . In the present study, increased cholesterol catabolism coupled with decreased microsomal free cholesterol levels was associated with a decrease in ACAT specific activity and ACAT-1 mRNA levels (ACAT-2 mRNA levels were not determined). As with cholesterol, in vitro addition of 25-hydroxycholesterol has previously been shown to stimulate ACAT activity (49) . More recently, in isolated membranes expressing ACAT activity, Cases et al. (5) found 27-hydroxycholesterol and 24(S),25-epoxycholesterol to be stimulators of ACAT activity, with 7-hydroxycholesterol a potent suppressor. On the basis of these observations, it has been suggested that oxysterols may be important regulators of ACAT. In this study, a repression in ACAT activity was associated with an increase in microsomal 7␣-hydroxycholesterol, an increase also associated with downregulation of HMGR. However, it is unclear in this study whether the change in ACAT activity is in response to a decrease in the regulatory cholesterol pool size in the liver or in response to the increase in 7␣-hydroxycholesterol. Transfection studies designed to assess the role of cholesterol availability in the regulation of ACAT specific activity, using the overexpression of ACAT in ACAT-deficient cell lines, have suggested that ACAT regulation is governed at both the transcriptional and posttranscriptional level (52) . The lesser decrease in steady-state mRNA levels compared with that observed in specific activity in response to overexpression of CYP7A1 supports this observation.
Recent findings have suggested that ACAT-2, primarily involved in lipoprotein assembly and secretion, is the predominant liver ACAT (38) . However, HepG2 cells contain both ACAT-1 and ACAT-2. Therefore, the activities of two different gene products are reflected in the measured ACAT activity. Whether the ACAT-1 and -2 functions are separate or can overlap in this cell line is uncertain. Only ACAT-1 mRNA levels were determined in this study. However, a decrease in mRNA levels was correlated with decreased ACAT activity.
CEH is the key enzyme required for releasing the pool of metabolically active free cholesterol from intracellular stores of cholesterol esters (14) . Thus neutral CEH is of great importance as an enzyme that replenishes the pool of free cholesterol for bile acid synthesis and biliary cholesterol secretion. This overexpression study of CYP7A1 clearly shows that enhanced bile acid synthesis is coupled with an increase in CEH specific activity, a means by which the size of the free cholesterol substrate pool is increased. The fact that an increase in CEH specific activity was coupled with an increase in mRNA levels also supports a transcriptional level of regulation of CEH. These data are consistent with primary observations showing that a cholesterol-enriched diet decreases CEH activity in rats and consistent with an increase in activity in response to cholestyramine feeding (12, 17) .
In summary, increased expression of CYP7A1 in primary human hepatocytes and in HepG2 cells resulted in increased bile acid synthesis via the classic pathway. The cholesterol homeostatic response in HepG2 cells included downregulation of HMGR, probably due to accumulation of 7␣-hydroxycholesterol, and upregulation of LDLR. This response suggests that overexpression of CYP7A1 in humans may be a useful approach for lowering serum cholesterol. Other effects of overexpression of CYP7A1 on ACAT and CEH are consistent with attempts of the liver to maintain cholesterol homeostasis in the face of a marked increase in cholesterol catabolism. The fact that the results in HepG2 cells and PHH agree with each other adds confidence that the results of this study in human cell lines may be extrapolated to an in vivo situation.
